171 related articles for article (PubMed ID: 23534458)
1. Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy on hemodialysis.
Takenaka T; Okayama M; Kojima E; Nodaira Y; Arai J; Uchida K; Kikuta T; Sueyoshi K; Hoshi H; Watanabe Y; Takane H; Suzuki H
Clin Exp Hypertens; 2013; 35(4):244-9. PubMed ID: 23534458
[TBL] [Abstract][Full Text] [Related]
2. Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy.
Takenaka T; Nobe K; Okayama M; Kojima E; Nodaira Y; Sueyoshi K; Hoshi H; Watanabe Y; Takane H; Suzuki H
Clin Exp Hypertens; 2012; 34(4):243-8. PubMed ID: 22559034
[TBL] [Abstract][Full Text] [Related]
3. Long-term antihypertensive effects of aliskiren, a direct renin inhibitor, in chronic hemodialysis patients.
Ishimitsu T; Ohta S; Ohno E; Takahashi T; Numabe A; Okamura A; Ohba S; Hashimoto A; Matsuoka H
Ther Apher Dial; 2013 Oct; 17(5):524-31. PubMed ID: 24107281
[TBL] [Abstract][Full Text] [Related]
4. Effects of aliskiren on blood pressure and humoral factors in hypertensive hemodialysis patients previously on angiotensin II receptor antagonists.
Ito T; Ishikawa E; Fujimoto N; Okubo S; Ito G; Ichikawa T; Nomura S; Ito M
Clin Exp Hypertens; 2014; 36(7):497-502. PubMed ID: 24433061
[TBL] [Abstract][Full Text] [Related]
5. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
de la Sierra A; Salazar J
Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.
Uzu T; Araki SI; Kashiwagi A; Haneda M; Koya D; Yokoyama H; Kida Y; Ikebuchi M; Nakamura T; Nishimura M; Takahara N; Obata T; Omichi N; Sakamoto K; Shingu R; Taki H; Nagai Y; Tokuda H; Kitada M; Misawa M; Nishiyama A; Kobori H; Maegawa H;
PLoS One; 2016; 11(12):e0164936. PubMed ID: 28033332
[TBL] [Abstract][Full Text] [Related]
7. Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.
Morishita Y; Hanawa S; Chinda J; Iimura O; Tsunematsu S; Kusano E
Hypertens Res; 2011 Mar; 34(3):308-13. PubMed ID: 21124333
[TBL] [Abstract][Full Text] [Related]
8. Aliskiren for the treatment of essential hypertension under real-life practice conditions: design and baseline data of the prospective 3A registry.
Zeymer U; Dechend R; Deeg E; Kaiser E; Senges J; Pittrow D; Schmieder R;
Int J Clin Pract; 2012 Mar; 66(3):251-61. PubMed ID: 22321062
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the antihypertensive and anti-inflammatory effects of aliskiren and ramipril add-on therapy in peritoneal dialysis patients--a pilot open label study.
Makówka A; Olejniczak-Fortak M; Nowicki M
Kidney Blood Press Res; 2012; 36(1):18-25. PubMed ID: 22777192
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren: an oral renin inhibitor for the treatment of hypertension.
Lam S; Choy M
Cardiol Rev; 2007; 15(6):316-23. PubMed ID: 18090068
[TBL] [Abstract][Full Text] [Related]
11. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunction.
Ito S; Nakura N; Le Breton S; Keefe D
Hypertens Res; 2010 Jan; 33(1):62-6. PubMed ID: 19927154
[TBL] [Abstract][Full Text] [Related]
13. Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
Silaratana S; Sumransurp S; Duangchana S; Tasanarong A
J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S18-23. PubMed ID: 23964439
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
Dalla Vestra M; Simioni N; Masiero A
Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
[TBL] [Abstract][Full Text] [Related]
15. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
Horký K
Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects.
Mazza A; Montemurro D; Zuin M; Schiavon L; Zorzan S; Chondrogiannis S; Ferretti A; Ramazzina E; Rubello D
Minerva Cardioangiol; 2013 Aug; 61(4):461-9. PubMed ID: 23846012
[TBL] [Abstract][Full Text] [Related]
17. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
[TBL] [Abstract][Full Text] [Related]
18. Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Abe M; Maruyama N; Suzuki H; Fujii Y; Ito M; Yoshida Y; Okada K; Soma M
Hypertens Res; 2012 Aug; 35(8):874-81. PubMed ID: 22592665
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients.
Siddiqi L; Oey PL; Blankestijn PJ
Nephrol Dial Transplant; 2011 Sep; 26(9):2930-4. PubMed ID: 21467128
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.
Stanton AV; Gradman AH; Schmieder RE; Nussberger J; Sarangapani R; Prescott MF
Hypertension; 2010 Jan; 55(1):54-60. PubMed ID: 19917876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
